Cyma Press Releases & News

Cyma Released StepWatch 3.1 Software

Seattle, WA May 16, 2005 -- Cyma Corporation released the StepWatch 3.1 software. This offers expanded analysis tools, display capability, and improved database functions.

StepWatch™ Receives FDA Clearance

Seattle, WA April 12, 2004 -- Cyma Corporation announced that it has received Food and Drug Administration marketing clearance for the StepWatch Step Activity Monitor (SAM) as a Class II device. [more...]

Cyma announces the completion of the StepWatch™ Activity Monitor (SAM) 3.0

Seattle, WA October 6, 2003—Cyma Corporation, a Seattle-based medical device company announces the completion of the StepWatch Activity Monitor (SAM) 3.0, the first commercial product of its kind to accurately measure patient ambulatory activity and objectively assess function.  Release is set for early October, to coincide with the annual meeting of the American Academy of Physical Medicine & Rehabilitation in Chicago. [more...]


Last updated: Wednesday, August 10, 2005